All In MedTech

FDA Clearance Tracker · P090012-S011

MELAFIND

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 18, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P090012-S011
Device name
MELAFIND
Applicant location
Horsham, PA
Received
Jun 11, 2015
Decided
Aug 18, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P090012

Device type

Device class
Class II
Regulation
21 CFR 878.1820

Every decision under product code OYD

FDA's approval statement

As written in FDA's record.

Approval for changing your calibration validation self-test method from the Field Phantom Imaging Self-Test to the Flap Shutter Self-Test.

Source documents

Other decisions for Strata Skin Sciences, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.